Immunostimulatory activity of cationic-lipid-nucleic-acid complexes against cancer

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 4, 2002, Pages 177-181

  Dass, C ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

Cancer; Cationic liposome; Immunostimulation; Lipoplex; Oligonucleotide

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIPOSOME; NUCLEIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; COMPLEX FORMATION; CPG ISLAND; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; HUMAN; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

CATIONS; CPG ISLANDS; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; ISCOMS; LIPIDS; LIPOSOMES; OLIGONUCLEOTIDES;

EID: 0036206064     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-001-0318-x     Document Type: Review

References (47)

1. Towards gene therapy for cystic fibrosis: A clinical progress report
2. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases
3. Activation of host tumoral responses by cationic lipid/DNA complexes
4. Enhanced dendritic cell maturation by TNF-α or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor responses in vivo
5. Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice
6. Lipoplexes and tumours
7. Delivery of lipoplexes for genotherapy of solid tumours: Role of vascular endothelial cells
8. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. I. Construction and in vitro evaluation
9. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumour model
10. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously
11. Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases
12. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12
13. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes
14. Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular network
15. Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A Phase I clinical trial
16. Cationic lipid: Bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal models
17. Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line
18. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors
19. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes
20. Multiple systemic expression of human interferon-β in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex
21. Immune stimulation by a CpG-containing oligodeoxynucleotide in enhanced when encapsulated and delivered in lipid particles
22. Non-antisense oligonucleotide approaches for experimental treatment of glioblastoma
23. A new temperature sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model
24. Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzmann reaction
25. Plasmid DNA gene therapy: Studies with the human interleukin-12 gene in tumor cells in vitro and in the murine B16 model in vivo
26. Liposome-mediated DNA vaccination: The effect of vesicle composition
27. Promoter attenuation in gene therapy: Interferon-γ and tumor necrosis factor-α inhibit transgene expression
28. Structural basis of DOTMA for its high intravenous transfection activity in mouse
29. Vaxfectin enhances antigen-specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization
30. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis
31. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung
32. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: Formation of novel small multilamellar vesicle structures
33. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model
34. Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-α-mediated shock
35. Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7/β2-microglobulin DNA-liposome complex, in patients with metastatic melanoma
36. The role of CXC chemokines as regulators of angiogenesis
37. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxy-nucleotides targeted against MDR1
38. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo
39. Immunoliposome-mediated gene transfer into cultured myotubes
40. Immunostimulalatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
41. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung
42. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth
43. Cationic lipid binding to DNA: Characterization of complex formation
44. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma
45. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid: pDNA complexes
46. Reduced inflammatory response to plasmid vectors by elimination and inhibition of immunostimulatory CpG motifs